GRG's Center For Experiential Learning

Managing Hypophosphatasia (HPP) continues to challenge physicians and patients alike, from delayed diagnoses and limited treatment options to gaps in awareness and collaboration. Through in-depth conversations with specialists across Canada, GRG Health uncovers the realities shaping HPP care in 2025 and the urgent need for education, teamwork, and faster insights to drive real change.

Molecular diagnostics has emerged as a transformative force in modern healthcare, playing a crucial role in early disease detection,...

Cardiovascular diseases remain the leading cause of morbidity and mortality worldwide, yet within this broad category, rare disorders...

With rapid advances in genetic testing and counseling, individuals now have unprecedented access to personal genetic information that...

Huntington’s Disease (HD) is a devastating genetic disorder that progressively affects the brain, leading to the gradual decline of...

Introduction: A New Era in Pharma The pharmaceutical landscape is rapidly evolving, with personalized medicine at the forefront of this...